Acta Neuropathologica

, Volume 88, Issue 6, pp 571–578 | Cite as

Sciatic nerve morphology and morphometry in mature rats with streptozocin-induced diabetes

  • A. Wright
  • H. Nukada
Regular Paper
Received:
Accepted:

Abstract

Controversy exists as to the morphological and morphometric changes seen in experimental diabetic neuropathy (EDN). Most previous studies have utilized immature animals, with controversy as to whether the observed changes are due to maturational delays induced by hyperglycemia, or to diabetes per se. This study utilizes mature 9-month-old Sprague-Dawley rats. Six control and six hyperglycemic rats were examined 24 weeks after streptozocin injection. No morphological abnormalities were seen in the sciatic nerve at the light microscopy level. Total fascicular area and myelinated fiber density showed no significant differences (ANOVA, P > 0.05). No significant differences [ANOVA, P > 0.05 and Kolmogorov-Smirnoff (K-S), P > 0.05] between control and diabetic groups were shown for fiber, axon, and myelin areas, fiber and axon diameters, and myelin thickness. Fiber index of circularity, axon index of circularity, and g ratio were not significantly different with ANOVA (P > 0.05), but the diabetic group showed significantly lower values (P < 0.001) with K-S testing. Regression analyses of axonal area and log(n) axonal area plotted against myelin thickness showed no significant differences between the control and diabetic animals. This study in mature rats confirms the relative lack of morphological and morphometric changes in EDN which have previously been reported in studies involving immature rats. It high-lights the difficulties in trying to extrapolate from EDN to human diabetic neuropathy where severe morphological and morphometric abnormalities may be present.

Key words

Diabetic neuropathy Streptozocin Morphometry Sciatic nerve 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Allpress S, Pollock M, Nukada H (1983) Morphometric analysis of peripheral nerve. In: Kidman AD, Tomkins JK, Morris CA, Cooper NA (eds) Molecular pathology of nerve and muscle. Human Press, Clifton, pp 131–161Google Scholar
  2. 2.
    Bestetti G, Rossi GL, Zemp C (1981) Changes in peripheral nerves of rats four months after induction of streptozocin diabetes. A qualitative and quantitative study. Acta Neuropathol (Berl) 54: 129–134Google Scholar
  3. 3.
    Bestetti G, Zemp C, Probst D, Rossi GL (1981) Neuropathy and myopathy in the diaphragm of rats after 12 months of streptozocin-induced diabetes mellitus. A light, electron microscopic and morphometric study. Acta Neuropathol (Berl) 55: 11–20Google Scholar
  4. 4.
    Brown MJ, Summer AJ, Greene DA, Diamond SM, Asbury AK (1980) Distal neuropathy in experimental diabetes mellitus. Ann Neurol 8: 168–178Google Scholar
  5. 5.
    Dockery P, Sharma AK (1990) Ultrastructural abnormalities of myelinated fibres in the tibial nerve of streptozotocin-diabetic rats. J Neurol Sci 98: 327–345Google Scholar
  6. 6.
    Dyck PJ, Lambert EH, Nichols PC (1971) Quantitative measurement of sensation related to compound action potential and number and sizes of myelinated and unmyelinated fibers of sural nerves in health, Friedreich's ataxia, hereditary sensory neuropathy, and tabes dorsalis. In: Cobb WA (ed) Handbook of electroencephalography and clinical neurophysiology. Elsevier, Amsterdam, pp 83–118Google Scholar
  7. 7.
    Dyck PJ, Karnes J, Lais A, Lofgren EP, Stevens JC (1984) Pathologic alterations of the peripheral nervous system of humans. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy, 2nd edn. Saunders, Philadelphia, pp 760–870Google Scholar
  8. 8.
    Jakobsen J (1976) Axonal dwindling in early experimental diabetes. I. A study of cross sectioned nerves. Diabetologia 12: 539–546Google Scholar
  9. 9.
    Jakobsen J (1978) Peripheral nerves in early experimental diabetes. Expansion of the endoneurial space as a cause of increased water content. Diabetologia 14: 113–119Google Scholar
  10. 10.
    Mayhew TM (1990) Efficient and unbiased sampling of nerve fibers for estimating fiber number and size. In: Conn PM (ed) Methods in neuroscience, vol 3. Quantitative and qualitative microscopy. Academic Press, New York, pp 172–187Google Scholar
  11. 11.
    Nukada H, Powell HC, Myers RR (1992) Perineurial window: demyelination in nonherniated endoneurium with reduced nerve blood flow. J Neuropathol Exp Neurol 51: 523–530Google Scholar
  12. 12.
    Pollock M, Dyck PJ (1976) Peripheral nerve morphometry in myotonic dystrophy. Arch Neurol 33: 33–39Google Scholar
  13. 13.
    Powell HC, Myers RR (1985) Axonopathy and microangiopathy in chronic alloxan diabetes. Acta Neuropathol (Berl) 68: 295–305Google Scholar
  14. 14.
    Sharma AK, Thomas PK (1974) Peripheral nerve structure and function in experimental diabetes. J Neurol Sci 23: 1–15Google Scholar
  15. 15.
    Sharma AK, Thomas PK (1987) Animal models: pathology and pathophysiology. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D Jr (eds) Diabetic neuropathy. Saunders, Philadelphia, pp 237–252Google Scholar
  16. 16.
    Sharma AK, Thomas PK, De Molina AF (1977) Peripheral nerve fiber size in experimental diabetes. Diabetes 26: 689–692Google Scholar
  17. 17.
    Sharma AK, Bajada S, Thomas PK (1980) Age changes in the tibial and plantar nerves of the rat. J Anat 130: 417–428Google Scholar
  18. 18.
    Sharma AK, Bajada S, Thomas PK (1981) Influence of streptozotocin-induced diabetes on myelinated nerve fibre maturation and on body growth in the rat. Acta Neuropathol (Berl) 53: 257–265Google Scholar
  19. 19.
    Sharma AK, Duguid IGM, Blanchard DS, Thomas PK (1985) The effect of insulin treatment on myelinated nerve fiber maturation and integrity and on body growth in streptozotocin-diabetic rats. J Neurol Sci 67: 285–297Google Scholar
  20. 20.
    Siegel S, Castellan NJ Jr (1988) Nonparametric statistics for the behavioral sciences, 2nd edn. McGraw-Hill, New York, pp 145–147Google Scholar
  21. 21.
    Sima AAF, Zhang W, Tze WJ, Tai J, Nathaniel V (1988) Diabetic neuropathy in STZ-induced diabetic rat and effect of allogeneic islet cell transplantation: morphometric analysis. Diabetes 37: 1129–1136Google Scholar
  22. 22.
    Sugimura K, Windebank AJ, Natarajan V, Lambert EH, Schmid HHO, Dyck PJ (1980) Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic nerve. J Neuropathol Exp Neurol 39: 710–721Google Scholar
  23. 23.
    Thomas PK (1990) The pathogenesis of diabetic neuropathy: current problems and prospects. In: Ward J, Goto Y (eds) Diabetic neuropathy. Wiley, Chichester, pp 3–14Google Scholar
  24. 24.
    Thomas PK, Eliasson SG (1984) Diabetic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy, 2nd edn. Saunders, Philadelphia, pp 1773–1810Google Scholar
  25. 25.
    Thomas PK, Fraher JP, O'Leary D, Moran MA, Cole M, King RHM (1990) Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 2. Effect of streptozotocin-induced diabetes. Acta Neuropathol 79: 375–386Google Scholar
  26. 26.
    Torch S, Stoebner P, Usson Y, Druet D'Aubigny G, Saxod R (1989) There is no simple adequate sampling scheme for estimating the myelinated fiber size distribution in human peripheral nerve: a statistical ultrastructural study. J Neurosci Methods 27: 149–164Google Scholar
  27. 27.
    Zemp C, Bestetti G, Rossi GL (1981) Morphological and morphometric study of peripheral nerves from rats with streptozocin-induced diabetes mellitus. Acta Neuropathol (Berl) 53: 99–106Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • A. Wright
    • 1
  • H. Nukada
    • 1
  1. 1.Department of NeurologyUniversity of Otago Medical SchoolDunedinNew Zealand

Personalised recommendations